Fund moves

Assembly Biosciences (ASMB)Paradigm Biocapital Advisors LP opened a new position $22.6M

Paradigm Biocapital Advisors LP opened a new position in Assembly Biosciences, per its Q4 2025 13F.

665K
Shares reported
0.58%
Disclosed portfolio weight
$22.6M
Reported value
Holdings as of
Dec 31, 2025
Filed
Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Mar 19, 2026Company filing · Form 8-K · ResultsReported its results
    2. Mar 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 24, 2026, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Assembly Biosciences, Inc. (the “Company”) approved a new cash bonus plan, the 2026 Corporate Bonus Plan (the “Plan”).”
    3. May 7, 2026Company filing · Form 8-K · ResultsReported its results
    4. May 21, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
    5. Jun 4, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Amendment No. 3 to Amended and Restated 2018 Stock Incentive Plan At the Assembly Biosciences, Inc. (the "Company") Annual Meeting of Stockholders held on June 4, 2026, (the "Annual Meeting"), the Company's stockholders approved Amendment No. 3 ("Amendment No. 3") to the Assembly Biosciences, Inc. Amended and Restated 2018 Stock Incentive Plan (the "2018 Plan") to increase the number of shares reserved for issuance…”
    View the official recordSEC Form 13F-HR

    How to read SEC Form 13F-HR

    Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

    Full guide: What is an SEC Form 13F?

    What else is on file for Assembly Biosciences

    For Assembly Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ASMB page.

    How this filing works

    Other disclosures at Assembly Biosciences

    Everything OQRO holds on this company is on its ASMB page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO Pro is a paid subscription. You see the price before you pay

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data